Mary Piotrowski
Pfizer (United States)(US)
Publications by Year
Research Areas
Drug Transport and Resistance Mechanisms, Amino Acid Enzymes and Metabolism, Metabolomics and Mass Spectrometry Studies, Cholinesterase and Neurodegenerative Diseases, Phosphodiesterase function and regulation
Most-Cited Works
- → Concentration-Dependent Modulation of Amyloid-β in Vivo and in Vitro Using the γ-Secretase Inhibitor, LY-450139(2006)133 cited
- → Quantitative Prediction of Human Renal Clearance and Drug-Drug Interactions of Organic Anion Transporter Substrates Using In Vitro Transport Data: A Relative Activity Factor Approach(2017)128 cited
- → Discovery, SAR, and Pharmacokinetics of a Novel 3-Hydroxyquinolin-2(1H)-one Series of Potentd-Amino Acid Oxidase (DAAO) Inhibitors(2009)109 cited
- → The RESOLUTE consortium: unlocking SLC transporters for drug discovery(2020)108 cited
- → Quantitative assessment of the contribution of sodium‐dependent taurocholate co‐transporting polypeptide (NTCP) to the hepatic uptake of rosuvastatin, pitavastatin and fluvastatin(2013)83 cited
- → Modulation of NMDA receptor function by inhibition of d-amino acid oxidase in rodent brain(2011)40 cited
- → Intracellular concentrations determine the cytotoxicity of adefovir, cidofovir and tenofovir(2014)33 cited
- → Application of Structure-Based Design and Parallel Chemistry to Identify a Potent, Selective, and Brain Penetrant Phosphodiesterase 2A Inhibitor(2017)32 cited
- → Identification of a Potent, Highly Selective, and Brain Penetrant Phosphodiesterase 2A Inhibitor Clinical Candidate(2018)27 cited
- → Development of A High-Speed, Multiplexed Sample-Delivery Instrument For Lc–MS/MS Bioanalysis(2012)26 cited